The Prostate Health Education Network: Prostate Health Education and Awareness

Clinical Trials

Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients Number: NCT00579514 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Not Applicable Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s):	Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy Number: NCT00969111 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Not Applicable Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s):
MRI for Assessing Prostate Cancer Response Number: NCT01607008 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Not Applicable Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s):	Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer Number: NCT01794403 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Not Applicable Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s):
Evaluation of CyberKnife Stereotactic Radiotherapy in Prostate Cancer Number: NCT02016248 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Not Applicable Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s):	A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts Number: NCT02266745 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Promontory Therapeutics Inc. Sponsor Trial Information Trial Location(s) and Contact(s):
Randomized MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated Radiotherapy Number: NCT02307058 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Not Applicable Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s):	Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer Number: NCT02420977 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Early Phase 1 Sponsor(s): Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins\|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s):
Study of TGF-Î² Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer Number: NCT02452008 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins\|Eli Lilly and Company Sponsor Trial Information Trial Location(s) and Contact(s):	Enzalutamide With and Without Ribociclib for Metastatic, Castrate-Resistant, Chemotherapy-Naive Prostate Cancer That Retains RB Expression Number: NCT02555189 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1\|Phase 2 Sponsor(s): Sidney Kimmel Cancer Center at Thomas Jefferson University\|Novartis\|Prostate Cancer Clinical Trials Consortium\|Thomas Jefferson University Sponsor Trial Information Trial Location(s) and Contact(s):
Safety and Activity Study of PSCA-Targeted CAR-T Cells (BPX-601) in Subjects With Selected Advanced Solid Tumors Number: NCT02744287 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1\|Phase 2 Sponsor(s): Bellicum Pharmaceuticals Sponsor Trial Information Trial Location(s) and Contact(s):	Pivotal Study of MRI-guided Transurethral Ultrasound Ablation in Patients With Localized Prostate Cancer Number: NCT02766543 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Not Applicable Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s):
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer Number: NCT02769962 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1\|Phase 2 Sponsor(s): National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC) Sponsor Trial Information Trial Location(s) and Contact(s):	PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer Number: NCT02933255 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1\|Phase 2 Sponsor(s): National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC) Sponsor Trial Information Trial Location(s) and Contact(s):
Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer Number: NCT02935205 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1\|Phase 2 Sponsor(s): Mamta Parikh\|National Cancer Institute (NCI)\|University of California, Davis Sponsor Trial Information Trial Location(s) and Contact(s):	Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects Number: NCT03012321 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Northwestern University\|AstraZeneca\|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s):
A Study of Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA Number: NCT03087903 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Not Applicable Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s):	Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis Number: NCT03317392 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1\|Phase 2 Sponsor(s): National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s):
Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer Number: NCT03361735 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): City of Hope Medical Center Sponsor Trial Information Trial Location(s) and Contact(s):	Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy Number: NCT03388619 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC) Sponsor Trial Information Trial Location(s) and Contact(s):
PET/MRI for the Staging of Newly Diagnosed Prostate Cancer Number: NCT03392181 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Early Phase 1 Sponsor(s): Northwestern University\|Progenics Pharmaceuticals, Inc. Sponsor Trial Information Trial Location(s) and Contact(s):	The "PC-LIGHT" Study Number: NCT03419585 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Not Applicable Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s):
Study to Evaluate CORT125281 in Combination With Enzalutamide in Patients With mCRPC Number: NCT03437941 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1\|Phase 2 Sponsor(s): Corcept Therapeutics Sponsor Trial Information Trial Location(s) and Contact(s):	RAD 1801: Pilot Study of Intra-Urethral Radiotransponder Beacon Guided Focal Prostate Stereotactic Body Radiotherapy Number: NCT03458234 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Not Applicable Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s):
PF-06821497 Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma Number: NCT03460977 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Pfizer Sponsor Trial Information Trial Location(s) and Contact(s):	Ultra-hypofractionated Radiation in Prostate Cancer Number: NCT03486821 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Not Applicable Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s):
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1) Number: NCT03493945 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1\|Phase 2 Sponsor(s): National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC) Sponsor Trial Information Trial Location(s) and Contact(s):	Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression Number: NCT03507608 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Early Phase 1 Sponsor(s): Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Sponsor Trial Information Trial Location(s) and Contact(s):
Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma Number: NCT03556228 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): VM Oncology, LLC Sponsor Trial Information Trial Location(s) and Contact(s):	Evaluation of Safety and Efficacy of KPG-121 Plus Enzalutamide, Abiraterone or Apalutamide in CRPC Patients Number: NCT03569280 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Kangpu Biopharmaceuticals, Ltd. Sponsor Trial Information Trial Location(s) and Contact(s):
A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer Number: NCT03574571 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 3 Sponsor(s): Memorial Sloan Kettering Cancer Center\|Bayer Sponsor Trial Information Trial Location(s) and Contact(s):	A Phase I/II Study of OBI-3424 in Subjects With Advanced Solid Tumors Number: NCT03592264 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1\|Phase 2 Sponsor(s): OBI Pharma, Inc Sponsor Trial Information Trial Location(s) and Contact(s):
SOR-C13 in Treating Patients With Advanced Refractory Solid Tumors Number: NCT03784677 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): M.D. Anderson Cancer Center\|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s):	HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer Number: NCT03802851 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Not Applicable Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s):
CyberKnife Dose Escalation Prostate Cancer Trial Number: NCT03822494 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Not Applicable Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s):	WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy Number: NCT03824652 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Stephen Freedland\|California Walnut Commission\|Cedars-Sinai Medical Center Sponsor Trial Information Trial Location(s) and Contact(s):
Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery Number: NCT03824808 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 4 Sponsor(s): University of Missouri-Columbia Sponsor Trial Information Trial Location(s) and Contact(s):	HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Number: NCT03850795 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 3 Sponsor(s): Hinova Pharmaceuticals USA, Inc. Sponsor Trial Information Trial Location(s) and Contact(s):
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors Number: NCT03866382 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s):	Trial of ARV-110 in Patients With Metastatic Castration Resistant Prostate Cancer Number: NCT03888612 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1\|Phase 2 Sponsor(s): Arvinas Androgen Receptor, Inc.\|Arvinas Inc. Sponsor Trial Information Trial Location(s) and Contact(s):
the Safety and Tolerability of Proxalutamide (GT0918) in Subjects With Metastatic Castrate Resistant Prostate Cancer Number: NCT03899467 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Suzhou Kintor Pharmaceutical Inc, Sponsor Trial Information Trial Location(s) and Contact(s):	CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone Number: NCT03934840 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Masonic Cancer Center, University of Minnesota Sponsor Trial Information Trial Location(s) and Contact(s):
Study of REGN5678 (Anti-PSMAxCD28) With Cemiplimab (Anti-PD-1) in Patients With Metastatic Castration-resistant Prostate Cancer Number: NCT03972657 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1\|Phase 2 Sponsor(s): Regeneron Pharmaceuticals Sponsor Trial Information Trial Location(s) and Contact(s):	A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors Number: NCT04032704 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Seagen Inc. Sponsor Trial Information Trial Location(s) and Contact(s):
Dose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPC Number: NCT04060394 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1\|Phase 2 Sponsor(s): Laekna Limited Sponsor Trial Information Trial Location(s) and Contact(s):	pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer Number: NCT04090528 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): University of Wisconsin, Madison\|Merck Sharp & Dohme LLC\|Madison Vaccines, Inc\|Prostate Cancer Foundation Sponsor Trial Information Trial Location(s) and Contact(s):
A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation Number: NCT04104893 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): VA Office of Research and Development\|Merck Sharp & Dohme LLC Sponsor Trial Information Trial Location(s) and Contact(s):	Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer. Number: NCT04116775 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Julie Graff, MD\|Merck Sharp & Dohme LLC\|Prostate Cancer Foundation\|Johns Hopkins University\|Oregon Health and Science University\|Portland VA Medical Center Sponsor Trial Information Trial Location(s) and Contact(s):
A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are Described Number: NCT04122976 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Sponsor(s): Bayer Sponsor Trial Information Trial Location(s) and Contact(s):	18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Life Prolonging Therapies Number: NCT04158245 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Tulane University\|Blue Earth Diagnostics Sponsor Trial Information Trial Location(s) and Contact(s):
CELLO-1, Study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Subjects With Castration Resistant Prostate Cancer Who Have Not Received Chemotherapy Number: NCT04179864 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1\|Phase 2 Sponsor(s): Epizyme, Inc. Sponsor Trial Information Trial Location(s) and Contact(s):	Addition of Opaganib to Androgen Antagonists in Patients With mCRPC Number: NCT04207255 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Medical University of South Carolina\|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s):
A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects Number: NCT04288687 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Abramson Cancer Center of the University of Pennsylvania Sponsor Trial Information Trial Location(s) and Contact(s):	An Investigational Scan (7 Tesla MRI) in Diagnosing Cognitive Impairment in Patients With Non-Metastatic Prostate Cancer Number: NCT04318028 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Not Applicable Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s):
Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide Number: NCT04335682 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Alliance Foundation Trials, LLC.\|Bayer Sponsor Trial Information Trial Location(s) and Contact(s):	Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer Number: NCT04337580 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Wake Forest University Health Sciences\|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s):
Biomarker Monitoring of Prostate Cancer Patients With RSI MRI (ProsRSI) Number: NCT04349501 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): University of California, San Diego Sponsor Trial Information Trial Location(s) and Contact(s):	Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression Number: NCT04363164 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins\|United States Department of Defense Sponsor Trial Information Trial Location(s) and Contact(s):
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer Number: NCT04381832 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1\|Phase 2 Sponsor(s): Arcus Biosciences, Inc. Sponsor Trial Information Trial Location(s) and Contact(s):	Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC Number: NCT04446117 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 3 Sponsor(s): Exelixis\|Roche-Genentech\|Takeda Sponsor Trial Information Trial Location(s) and Contact(s):
A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy Number: NCT04455750 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 3 Sponsor(s): Alliance for Clinical Trials in Oncology\|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s):	Study in Patients With Advanced Cancers Associated With Expression of DLL3 Who Have Failed Standard Available Therapy Number: NCT04471727 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1\|Phase 2 Sponsor(s): Harpoon Therapeutics Sponsor Trial Information Trial Location(s) and Contact(s):
ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer Number: NCT04471974 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Rahul Aggarwal\|Zenith Epigenetics\|Merck Sharp & Dohme LLC\|U.S. Army Medical Research and Development Command\|University of California, San Francisco Sponsor Trial Information Trial Location(s) and Contact(s):	A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors Number: NCT04478279 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1\|Phase 2 Sponsor(s): Sapience Therapeutics Sponsor Trial Information Trial Location(s) and Contact(s):
Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048) Number: NCT04486755 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): University of Maryland, Baltimore Sponsor Trial Information Trial Location(s) and Contact(s):	Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV Number: NCT04514484 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s):
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations Number: NCT04521686 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Eli Lilly and Company\|Loxo Oncology, Inc. Sponsor Trial Information Trial Location(s) and Contact(s):	A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Prostate-Specific Membrane Antigen-Positron Emission Tomography (PSMA-PET) Positive Hormone-Sensitive Prostate Cancer Participants Number: NCT04557059 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 3 Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s):
A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer Number: NCT04564027 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): AstraZeneca Sponsor Trial Information Trial Location(s) and Contact(s):	Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer Number: NCT04592237 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): M.D. Anderson Cancer Center\|Janssen Pharmaceutica Sponsor Trial Information Trial Location(s) and Contact(s):
To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring Number: NCT04597359 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): ECOG-ACRIN Cancer Research Group\|National Cancer Institute (NCI)\|Eastern Cooperative Oncology Group Sponsor Trial Information Trial Location(s) and Contact(s):	Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial Number: NCT04624256 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Not Applicable Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s):
A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence Number: NCT04645810 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Early Phase 1 Sponsor(s): University of Rochester Sponsor Trial Information Trial Location(s) and Contact(s):	Preliminary Effectiveness of Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Locally Confined Intermediate Risk Prostate Cancer Number: NCT04656678 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Not Applicable Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s):
Insulin Resistance Following ADT for Prostate CA Number: NCT04658849 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Early Phase 1 Sponsor(s): St. Louis University Sponsor Trial Information Trial Location(s) and Contact(s):	ARX517 in Subjects With Advanced Solid Tumor Number: NCT04662580 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Ambrx, Inc. Sponsor Trial Information Trial Location(s) and Contact(s):
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer Number: NCT04692675 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Not Applicable Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s):	Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging Number: NCT04698564 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): University of Maryland, Baltimore Sponsor Trial Information Trial Location(s) and Contact(s):
68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer Number: NCT04716725 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): University of California, San Francisco\|Conquer Cancer Foundation\|Gateway for Cancer Research\|Prostate Cancer Foundation Sponsor Trial Information Trial Location(s) and Contact(s):	Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer Number: NCT04725903 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Not Applicable Sponsor(s): Emory University\|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s):
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer Number: NCT04731844 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): University of Rochester Sponsor Trial Information Trial Location(s) and Contact(s):	Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer Number: NCT04743934 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Andrew McDonald\|University of Alabama at Birmingham Sponsor Trial Information Trial Location(s) and Contact(s):
The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors Number: NCT04768868 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Impact Therapeutics, Inc.\|Covance Sponsor Trial Information Trial Location(s) and Contact(s):	An Investigational Scan (68Ga-PSMA-11 PET/CT) for the Imaging of Prostate Cancer Number: NCT04777071 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): University of Washington Sponsor Trial Information Trial Location(s) and Contact(s):
Phase II Study of Pencil Beam Scanning Proton Stereotactic Body Radiation Therapy for Prostate Cancer Number: NCT04842890 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): The New York Proton Center Sponsor Trial Information Trial Location(s) and Contact(s):	Diet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With Prostate Cancer, TRIPLE-A PILOT Study Number: NCT04870515 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Not Applicable Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s):
Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization Number: NCT04879940 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): H. Lee Moffitt Cancer Center and Research Institute Sponsor Trial Information Trial Location(s) and Contact(s):	Study of XB002 in Subjects With Solid Tumors (JEWEL-101) Number: NCT04925284 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Exelixis Sponsor Trial Information Trial Location(s) and Contact(s):
11C-YJH08 PET Imaging for the Detection of Glucocorticoid Receptor Expression in Patients With Metastatic Prostate Cancer Number: NCT04927663 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Michael Evans\|U.S. Army Medical Research Acquisition Activity\|National Institute of Mental Health (NIMH)\|University of California, San Francisco Sponsor Trial Information Trial Location(s) and Contact(s)	Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer Number: NCT04943536 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Alessa Therapeutics Inc.\|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s):
Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue Number: NCT04972097 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Not Applicable Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s):	Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion Number: NCT04976257 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Early Phase 1 Sponsor(s): Ryan Kohlbrenner, MD\|Radiological Society of North America\|University of California, San Francisco Sponsor Trial Information Trial Location(s) and Contact(s):
Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer Number: NCT04984343 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Weill Medical College of Cornell University\|Viewray Inc.\|Progenics Pharmaceuticals, Inc. Sponsor Trial Information Trial Location(s) and Contact(s):	Differences in Immunological Effects of Vitamin D Replacement Among African American Prostate Cancer Patients With Localized Versus Metastatic Disease Number: NCT05045066 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Early Phase 1 Sponsor(s): Mayo Clinic\|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s):
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score Number: NCT05050084 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 3 Sponsor(s): NRG Oncology\|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s):	18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy Number: NCT05155046 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC) Sponsor Trial Information Trial Location(s) and Contact(s):
A Study of PRT2527 in Patients With Advanced Solid Tumors Number: NCT05159518 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Prelude Therapeutics Sponsor Trial Information Trial Location(s) and Contact(s):	Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy Number: NCT05160597 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Early Phase 1 Sponsor(s): Jonsson Comprehensive Cancer Center Sponsor Trial Information Trial Location(s) and Contact(s):
A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer Number: NCT05169970 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Memorial Sloan Kettering Cancer Center Sponsor Trial Information Trial Location(s) and Contact(s):	Study of NGM831 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors Number: NCT05215574 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): NGM Biopharmaceuticals, Inc\|Merck Sharp & Dohme LLC Sponsor Trial Information Trial Location(s) and Contact(s):
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors Number: NCT05311618 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): NGM Biopharmaceuticals, Inc\|Merck Sharp & Dohme LLC Sponsor Trial Information Trial Location(s) and Contact(s):	RElugolix VErsus LeUprolide Cardiac Trial Number: NCT05320406 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 4 Sponsor(s): Emory University\|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s):
Leveraging Technology to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation Therapy Number: NCT05324098 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Not Applicable Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s):	Patient-Reported Erectile Recovery and Quality of Life Outcomes With Lyopreserved Placental Tissue Applied Directly Over Neurovascular Bundle During Nerve Sparing Radical Prostatectomy Versus Standard of Care Number: NCT05366842 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Johns Hopkins University Sponsor Trial Information Trial Location(s) and Contact(s):
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies Number: NCT05417594 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1\|Phase 2 Sponsor(s): AstraZeneca Sponsor Trial Information Trial Location(s) and Contact(s):	177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study Number: NCT05496959 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s):

Total: 106 Clinical Trials

PHEN,Inc. © 2023 All rights reserved